Market Closed -
Nasdaq
04:30:01 2024-07-12 pm EDT
|
5-day change
|
1st Jan Change
|
2.746
USD
|
-0.34%
|
|
-0.77%
|
-40.83%
|
Fiscal Period: June |
2022
|
2023
|
---|
Capitalization
1 |
7,167
|
4,373
|
Enterprise Value (EV)
1 |
7,130
|
4,340
|
P/E ratio
|
-447
x
|
-212
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
9,161
x
|
4,313
x
|
EV / Revenue
|
9,113
x
|
4,281
x
|
EV / EBITDA
|
-
|
-246
x
|
EV / FCF
|
-1,568
x
|
-578
x
|
FCF Yield
|
-0.06%
|
-0.17%
|
Price to Book
|
201
x
|
52
x
|
Nbr of stocks (in thousands)
|
320,584
|
396,753
|
Reference price
2 |
22.36
|
11.02
|
Announcement Date
|
9/19/22
|
8/30/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1.012
|
1.178
|
0.6094
|
1.898
|
0.7824
|
1.014
|
EBITDA
1 |
-2.942
|
-2.647
|
-3.652
|
-
|
-
|
-17.68
|
EBIT
1 |
-2.996
|
-2.689
|
-3.694
|
-6.939
|
-11.35
|
-17.71
|
Operating Margin
|
-296.03%
|
-228.15%
|
-606.16%
|
-365.67%
|
-1,450.78%
|
-1,746.78%
|
Earnings before Tax (EBT)
1 |
-3.211
|
-2.87
|
-3.929
|
-8.164
|
-14.9
|
-19.98
|
Net income
1 |
-2.948
|
-2.718
|
-4.698
|
-8.164
|
-14.9
|
-19.98
|
Net margin
|
-291.24%
|
-230.67%
|
-770.83%
|
-430.21%
|
-1,904.94%
|
-1,970.61%
|
EPS
2 |
-0.0520
|
-0.0244
|
-0.0275
|
-0.0334
|
-0.0500
|
-0.0520
|
Free Cash Flow
1 |
-1.664
|
-1.668
|
-1.885
|
-3.054
|
-4.548
|
-7.503
|
FCF margin
|
-164.35%
|
-141.58%
|
-309.26%
|
-160.96%
|
-581.25%
|
-739.99%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/2/18
|
8/30/19
|
8/14/20
|
8/30/21
|
9/19/22
|
8/30/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.03
|
0.03
|
3.6
|
9.12
|
37.5
|
32.6
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1.66
|
-1.67
|
-1.88
|
-3.05
|
-4.55
|
-7.5
|
ROE (net income / shareholders' equity)
|
1,068%
|
679%
|
-286%
|
-139%
|
-67.1%
|
-33.3%
|
ROA (Net income/ Total Assets)
|
-219%
|
-274%
|
-97.1%
|
-63.9%
|
-30.1%
|
-17.5%
|
Assets
1 |
1.344
|
0.9915
|
4.836
|
12.77
|
49.59
|
114.1
|
Book Value Per Share
2 |
-0.0100
|
-0
|
0.0200
|
0.0300
|
0.1100
|
0.2100
|
Cash Flow per Share
2 |
0
|
0
|
0.0200
|
0.0300
|
0.1200
|
0.0800
|
Capex
1 |
0.05
|
0.02
|
-
|
-
|
-
|
0.48
|
Capex / Sales
|
4.7%
|
2.07%
|
-
|
-
|
-
|
47.03%
|
Announcement Date
|
9/2/18
|
8/30/19
|
8/14/20
|
8/30/21
|
9/19/22
|
8/30/23
|
|
1st Jan change
|
Capi.
|
---|
| -40.83% | 43.58M | | +12.92% | 4.95B | | -32.29% | 3.6B | | -4.28% | 3.03B | | -24.21% | 2.66B | | -8.82% | 2.34B | | +39.33% | 1.85B | | +40.81% | 1.45B | | -14.27% | 1.41B | | +41.90% | 1.38B |
Alternative Medicine
|